BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.371,11 PKT -4,74 PKT -0,34 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
23.01.18 UBS Hold S&P Capital IQ
22.01.18 UBS Neutral Goldman Sachs Group Inc.
22.01.18 Holcim Neutral UBS AG
22.01.18 UBS overweight JP Morgan Chase & Co.
22.01.18 UBS overweight Morgan Stanley
22.01.18 Nestlé Equal weight Barclays Capital
22.01.18 ABB (Asea Brown Boveri) Conviction Buy List Goldman Sachs Group Inc.
22.01.18 UBS Hold Deutsche Bank AG
22.01.18 Swiss Re Reduce Commerzbank AG
22.01.18 Zurich Insurance Reduce Commerzbank AG
19.01.18 Novartis overweight Morgan Stanley
19.01.18 ABB (Asea Brown Boveri) Conviction Buy List Goldman Sachs Group Inc.
19.01.18 Swiss Re buy HSBC
19.01.18 Zurich Insurance buy HSBC
18.01.18 Novartis Neutral JP Morgan Chase & Co.
18.01.18 Zurich Insurance Underperform Macquarie Research
18.01.18 UBS Outperform Credit Suisse Group
17.01.18 Nestlé buy Baader Bank
17.01.18 Nestlé buy S&P Capital IQ
17.01.18 Nestlé buy Kepler Cheuvreux
17.01.18 Roche Hold Kepler Cheuvreux
17.01.18 UBS buy Goldman Sachs Group Inc.
17.01.18 UBS Neutral Goldman Sachs Group Inc.
17.01.18 Nestlé overweight JP Morgan Chase & Co.
17.01.18 Roche Hold Deutsche Bank AG
17.01.18 Swiss Re Neutral Credit Suisse Group
17.01.18 Nestlé buy Goldman Sachs Group Inc.
17.01.18 ABB (Asea Brown Boveri) buy Deutsche Bank AG
17.01.18 ABB (Asea Brown Boveri) Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
16.01.18 Swiss Re kaufen DZ BANK
16.01.18 Zurich Insurance Neutral UBS AG
16.01.18 Holcim Outperform Bernstein Research
16.01.18 Nestlé buy Citigroup Corp.
16.01.18 Swiss Re Sector Perform RBC Capital Markets
16.01.18 UBS Underweight Barclays Capital
16.01.18 UBS Underweight Barclays Capital
15.01.18 Zurich Insurance Neutral JP Morgan Chase & Co.
15.01.18 Roche Neutral UBS AG
15.01.18 Novartis Neutral UBS AG
15.01.18 Roche Hold Deutsche Bank AG